PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aethlon Medical Inc (AEMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00808Y3071
CUSIP00808Y307
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$4.48M
EPS-$5.01
Revenue (TTM)$574.25K
Gross Profit (TTM)$574.25K
EBITDA (TTM)-$11.40M
Year Range$1.40 - $7.20
Target Price$25.00
Short %0.28%
Short Ratio1.16

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AEMD

Aethlon Medical Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aethlon Medical Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%OctoberNovemberDecember2024FebruaryMarch
-100.00%
364.90%
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aethlon Medical Inc had a return of -23.29% year-to-date (YTD) and -55.40% in the last 12 months. Over the past 10 years, Aethlon Medical Inc had an annualized return of -49.25%, while the S&P 500 had an annualized return of 10.89%, indicating that Aethlon Medical Inc did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-23.29%10.16%
1 month-3.45%3.47%
6 months-20.38%22.20%
1 year-55.40%30.45%
5 years (annualized)-59.18%13.16%
10 years (annualized)-49.25%10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-16.89%-5.49%
2023-24.97%-17.89%-35.78%31.03%15.26%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Aethlon Medical Inc (AEMD) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AEMD
Aethlon Medical Inc
-0.68
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Aethlon Medical Inc Sharpe ratio is -0.68. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.68
2.79
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Aethlon Medical Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-100.00%
0
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aethlon Medical Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aethlon Medical Inc was 100.00%, occurring on Oct 18, 2023. The portfolio has not yet recovered.

The current Aethlon Medical Inc drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%May 10, 20005391Oct 18, 2023
-22.22%Feb 25, 20001Feb 25, 20006Mar 31, 20007
-22.22%Apr 17, 20001Apr 17, 20001Apr 25, 20002
-20%Oct 8, 19992Oct 19, 19998Jan 10, 200010
-17.65%May 19, 19995Aug 11, 19991Sep 27, 19996

Volatility

Volatility Chart

The current Aethlon Medical Inc volatility is 10.93%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%OctoberNovemberDecember2024FebruaryMarch
10.93%
2.80%
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aethlon Medical Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items